Quick Hits

• Nvidia (NVDA) unveiled a massive $150 billion increase to its share buyback program, per Seeking Alpha — a show of financial firepower from the world's largest company, now valued at roughly $5.4 trillion.
• The 10-year Treasury hit 5.23% Friday, its highest level since 2007, and MarketWatch warns the upcoming jobs report could send 10- and 30-year yields surging while pressuring the Fed toward another hike in October. The central bank already raised rates Sept. 16 — its first hike since 2023 — with inflation running above 3% against a 2% target.
• Meta (META) rose 13% for the week and is up roughly 30% in September on enthusiasm for its new Muse personal AI agent, closing Thursday at $779.
• Oct. 1 is loaded: Nike (NKE) reports earnings with shares down 77% from their 2021 peak, and Nebius (NBIS) raises on-demand AI compute prices the same day — a real-time read on the compute shortage.
• The bear-market chorus is swelling even as the S&P 500 logs its two-dozen-plus record high of 2026, with a 5%-plus risk-free yield now the competition for investor dollars.

Markets Overview

The tape remains resilient but increasingly narrative-driven. The S&P 500 has notched more than two dozen record highs in 2026 despite stubborn inflation and global economic turbulence, per Motley Fool, and Meta's Muse-fueled surge — driven by its new personal AI agent and companion devices — was the week's standout move. One r/investing poster who owns the stock argues the market still prices META as "just an ad company" even after the AI optionality showed up.

The mega-cap hierarchy: Nvidia sits at ~$5.4 trillion, Apple (AAPL) just under $5 trillion, per Fool's head-to-head. Meanwhile SpaceX (SPCX), public since its June IPO, has swelled to roughly $1.95 trillion — ahead of Tesla's (TSLA) $1.5 trillion. Amazon (AMZN) trades 12% below its Aug. 3 record close of $284.02, a level it reached after jumping ~21% in two days on Q2 results. In crypto, Hyperliquid (HYPE) is up an eye-popping 284% year-to-date at fresh all-time highs, while XRP has still never broken $4.

Fed & Economic Data

The defining story is the return of the hiking cycle. The Fed's Sept. 16 increase — its first since 2023 — followed a decidedly hawkish August speech from new Fed Chairman Kevin Warsh, who per Fool is signaling higher-for-longer with inflation above target. The benchmark 10-year yield reached 5.23% Friday; by comparison, its highest close in all of 2023 was just under 5%.

MarketWatch cautions that another hot jobs report could push long yields higher still and pressure the Fed to act again in October. For income investors, the repricing has created openings: tax-equivalent municipal bond yields have widened dramatically over corporates during the past two months, which MarketWatch calls a sweet spot worth acting on before it closes.

On the equity side of the ledger, Fool notes the 10-year's 5.2% yield means the S&P 500 needs only about 4% earnings growth to keep pace with risk-free paper. Policy risk is also resurfacing: President Trump has floated a partial or full diesel export ban, which Fool warns would carry "catastrophic" unintended consequences — part of what one column dubs the "next phase of Trumpflation" that's terrible news for both the Fed and Wall Street. Meanwhile, MarketWatch's five-year inflation retrospective ($6 eggs, $50,000 cars) is a reminder of what's crushing consumer confidence, and the 2027 Social Security COLA announcement — which Fool says could be a huge win for seniors — is imminent.

Earnings Reports

• Nike (NKE), reporting Oct. 1, has fallen 77% from its late-2021 peak and is down about 44% in 2026; Fool weighs whether that's a buying opportunity or a value trap.
• PepsiCo (PEP): Deutsche Bank turned bearish on the stock amid ongoing turnaround struggles, per Seeking Alpha.
• Zymeworks (ZYME) outlined guidance following its Theravance acquisition, per Seeking Alpha.
• Nebius (NBIS) raises its on-demand rate for Nvidia compute on Oct. 1 — a price increase Fool reads as fresh evidence of how tight AI compute supply remains.
• Eli Lilly (LLY): Fool flags "game-changing" news for a portfolio increasingly supercharged by its GLP-1 drug franchise.
• Healthcare divergence: Bristol Myers Squibb (BMY) raised its 2026 revenue outlook in July, while Novo Nordisk (NVO) heads in the opposite direction, per Fool.

Stock News

Beyond the $150 billion buyback expansion, Elon Musk delivered what Fool calls more good news for Nvidia investors in a Friday post on X. Elsewhere: GE Aerospace (GE) is spending nearly $12 billion to acquire Consolidated Precision Products (announced Sept. 8), prompting Fool to ask whether it's still the best aerospace stock to own. Blue Owl Capital (OWL) yields about 9% after falling 45% from its high — though the dividend-safety question lingers after its 2026 move to limit withdrawals from some non-traded private credit funds. On the brighter side, Target (TGT) is up about 61% year-to-date and carries a 55-year dividend-increase streak, making it what Fool calls an overlooked Dividend King, and a Fool contributor keeps adding to midstream operator Williams Companies (WMB) for reasons beyond the payout.

Market Analysis

The week's core tension: stocks at record highs versus a 5%-plus risk-free alternative. Fool frames it generously — the S&P needs only ~4% earnings growth to keep pace with Treasuries — while other Fool columns counter that history says a bear market is coming and that a crash is predictable, with a third arguing that 155 years of data shows investors who follow one discipline can still come out on top. For income portfolios, Warsh's higher-for-longer posture has direct read-throughs for big pharma dividend stocks, per Fool, and the muni-corporate yield gap favors tax-free bonds, per MarketWatch.

What to watch: the jobs report (and its implications for 10- and 30-year yields and a possible October hike), Nike's Oct. 1 print, Nebius's compute repricing, and the Social Security COLA reveal.